Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,984 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reprogramming CBX8-PRC1 function with a positive allosteric modulator.
Suh JL, Bsteh D, Hart B, Si Y, Weaver TM, Pribitzer C, Lau R, Soni S, Ogana H, Rectenwald JM, Norris JL, Cholensky SH, Sagum C, Umana JD, Li D, Hardy B, Bedford MT, Mumenthaler SM, Lenz HJ, Kim YM, Wang GG, Pearce KH, James LI, Kireev DB, Musselman CA, Frye SV, Bell O. Suh JL, et al. Among authors: kim ym. Cell Chem Biol. 2022 Apr 21;29(4):555-571.e11. doi: 10.1016/j.chembiol.2021.10.003. Epub 2021 Oct 28. Cell Chem Biol. 2022. PMID: 34715055 Free PMC article.
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia.
Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM. Kruse A, et al. Among authors: kim ym, kim hn. Int J Mol Sci. 2020 Feb 5;21(3):1054. doi: 10.3390/ijms21031054. Int J Mol Sci. 2020. PMID: 32033444 Free PMC article. Review.
Wnt Signaling in the Tumor Microenvironment.
Ruan Y, Ogana H, Gang E, Kim HN, Kim YM. Ruan Y, et al. Among authors: kim ym, kim hn. Adv Exp Med Biol. 2021;1270:107-121. doi: 10.1007/978-3-030-47189-7_7. Adv Exp Med Biol. 2021. PMID: 33123996 Free PMC article.
Cadherins, Selectins, and Integrins in CAM-DR in Leukemia.
Kim HN, Ruan Y, Ogana H, Kim YM. Kim HN, et al. Among authors: kim ym. Front Oncol. 2020 Dec 10;10:592733. doi: 10.3389/fonc.2020.592733. eCollection 2020. Front Oncol. 2020. PMID: 33425742 Free PMC article. Review.
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia.
Ruan Y, Kim HN, Ogana HA, Wan Z, Hurwitz S, Nichols C, Abdel-Azim N, Coba A, Seo S, Loh YE, Gang EJ, Abdel-Azim H, Hsieh CL, Lieber MR, Parekh C, Pal D, Bhojwani D, Durden DL, Kim YM. Ruan Y, et al. Among authors: kim ym, kim hn. Front Oncol. 2021 Dec 1;11:766888. doi: 10.3389/fonc.2021.766888. eCollection 2021. Front Oncol. 2021. PMID: 34926269 Free PMC article.
PI3K Targeting in Non-solid Cancer.
Kim HN, Ogana H, Sanchez V, Nichols C, Kim YM. Kim HN, et al. Among authors: kim ym. Curr Top Microbiol Immunol. 2022;436:393-407. doi: 10.1007/978-3-031-06566-8_17. Curr Top Microbiol Immunol. 2022. PMID: 36243854 Free PMC article. Review.
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.
Ogana HA, Hurwitz S, Hsieh CL, Geng H, Müschen M, Bhojwani D, Wolf MA, Larocque J, Lieber MR, Kim YM. Ogana HA, et al. Among authors: kim ym. Front Cell Dev Biol. 2023 Mar 31;11:1134121. doi: 10.3389/fcell.2023.1134121. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37082620 Free PMC article.
3,984 results